EUA
Oral formulations of doxycycline products for the post-exposure prophylaxis (PEP) of inhalational anthrax
FDA Emergency Use Authorization · Oct 14, 2011
Key facts
| Product | Oral formulations of doxycycline products for the post-exposure prophylaxis (PEP) of inhalational anthrax |
|---|---|
| Date | Oct 14, 2011 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: